TDF 300mg / 3TC 300mg, tab.
STD
DORATELA1T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
07/11/2024, 18:45:09
Former
Code(s):
-X DORAZYN1001 DORATELA3T3
6.4.2.5 - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR12
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
TENOFOVIR (TDF) / LAMIVUDINE (3TC)
- In the WHO list of Essential Medicines 2023 (Therapeutic alternative to emtricitabine + tenofovir)
Therapeutic Action
Fixed-dose combination (FDC) of two antiretrovirals, nucleoside reverse-transcriptase inhibitors (NRTI)
Indications
HIV infection according to strengths recommended by WHO.
Pre-Exposure Prophylaxis (PrEP)
Instructions for use
Should be used in combination with other antiretrovirals.
Can be used for PrEP.
Storage
Below 25ºC
![[KMEDMPEP03-] MODULE, PEP, post exposure prophylaxis for AIDS 2021](/web/image/product.template/574028/image_256/%5BKMEDMPEP03-%5D%20MODULE%2C%20PEP%2C%20post%20exposure%20prophylaxis%20for%20AIDS%202021?unique=28a5dd2)